Table of Content

1. Preface
    1.1. Market Definition and Scope
    1.2. Market Segmentation
    1.3. Key Research Objectives
    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Exosome Technologies Market

4. Market Overview
    4.1. Introduction
        4.1.1. Exosome Type Definition
        4.1.2. Industry Evolution/Developments
    4.2. Overview
    4.3. Market Dynamics
        4.3.1. Drivers
        4.3.2. Restraints
        4.3.3. Opportunities
    4.4. Global Exosome Technologies Market Analysis and Forecasts, 2017 - 2031
        4.4.1. Market Revenue Projections (US$ Mn)
        4.4.2. Market Volume/Unit Shipments Projections

5. Key Insights
    5.1. Pipeline Analysis
    5.2. Technological Advancements
    5.3. COVID-19 Pandemic Impact on Industry (value chain and short/mid/long term impact)

6. Global Exosome Technologies Market Analysis and Forecasts, by Exosome Type
    6.1. Introduction & Definition
    6.2. Key Findings / Developments
    6.3. Market Value Forecast By Exosome Type, 2017 - 2031
        6.3.1. Loaded Cargos
            6.3.1.1. Peptide
            6.3.1.2. siRNA
            6.3.1.3. mRNA
            6.3.1.4. miRNA
            6.3.1.5. Protein
            6.3.1.6. Chemical
            6.3.1.7. Others
        6.3.2. Non-cargo
    6.4. Market Attractiveness By Exosome Type

7. Global Exosome Technologies Market Analysis and Forecasts, by Cell Source
    7.1. Introduction & Definition
    7.2. Key Findings / Developments
    7.3. Market Value Forecast By Cell Source, 2017 - 2031
        7.3.1. HEK293 Cells
        7.3.2. MSCs
        7.3.3. Platelets
        7.3.4. Erythrocytes
        7.3.5. Natural Killer Cells
        7.3.6. Others
    7.4. Market Attractiveness By Cell Source

8. Global Exosome Technologies Market Analysis and Forecasts, by Application
    8.1. Introduction & Definition
    8.2. Key Findings / Developments
    8.3. Market Value Forecast By Application, 2017 - 2031
        8.3.1. Therapeutics
            8.3.1.1. Oncology
            8.3.1.2. Neurodegenerative Diseases
            8.3.1.3. Cardiovascular Diseases
            8.3.1.4. Infectious Diseases
            8.3.1.5. Cosmetics
        8.3.2. Diagnostics
    8.4. Market Attractiveness By Application

9. Global Exosome Technologies Market Analysis and Forecasts, by End-user
    9.1. Introduction & Definition
    9.2. Key Findings / Developments
    9.3. Market Value Forecast By End-user, 2017 - 2031
        9.3.1. Health Care Providers
        9.3.2. Pharmaceutical & Biotechnology Companies
        9.3.3. Others
    9.4. Market Attractiveness By End-user

10. Global Exosome Technologies Market Analysis and Forecasts, by Region
    10.1. Key Findings
    10.2. Market Value Forecast By Region
        10.2.1. North America
        10.2.2. Europe
        10.2.3. Asia Pacific
        10.2.4. Latin America
        10.2.5. Middle East & Africa
    10.3. Market Attractiveness By Country/Region

11. North America Exosome Technologies Market Analysis and Forecast
    11.1. Introduction
        11.1.1. Key Findings
    11.2. Market Value Forecast By Exosome Type, 2017 - 2031
        11.2.1. Loaded Cargos
            11.2.1.1. Peptide
            11.2.1.2. siRNA
            11.2.1.3. mRNA
            11.2.1.4. miRNA
            11.2.1.5. Protein
            11.2.1.6. Chemical
            11.2.1.7. Others
        11.2.2. Non-cargo
    11.3. Market Value Forecast By Cell Source, 2017 - 2031
        11.3.1. HEK293 Cells
        11.3.2. MSCs
        11.3.3. Platelets
        11.3.4. Erythrocytes
        11.3.5. Natural Killer Cells
        11.3.6. Others
    11.4. Market Value Forecast By Application, 2017 - 2031
        11.4.1. Therapeutics
            11.4.1.1. Oncology
            11.4.1.2. Neurodegenerative Diseases
            11.4.1.3. Cardiovascular Diseases
            11.4.1.4. Infectious Diseases
            11.4.1.5. Cosmetics
        11.4.2. Diagnostics
    11.5. Market Value Forecast By End-user, 2017 - 2031
        11.5.1. Health Care Providers
        11.5.2. Pharmaceutical & Biotechnology Companies
        11.5.3. Others
    11.6. Market Value Forecast By Country, 2017 - 2031
        11.6.1. U.S.
        11.6.2. Canada
    11.7. Market Attractiveness Analysis
        11.7.1. By Exosome Type
        11.7.2. By Cell Source
        11.7.3. By Application
        11.7.4. By End-user
        11.7.5. By Country

12. Europe Exosome Technologies Market Analysis and Forecast
    12.1. Introduction
        12.1.1. Key Findings
    12.2. Market Value Forecast By Exosome Type, 2017 - 2031
        12.2.1. Loaded Cargos
            12.2.1.1. Peptide
            12.2.1.2. siRNA
            12.2.1.3. mRNA
            12.2.1.4. miRNA
            12.2.1.5. Protein
            12.2.1.6. Chemical
            12.2.1.7. Others
        12.2.2. Non-cargo
    12.3. Market Value Forecast By Cell Source, 2017 - 2031
        12.3.1. HEK293 Cells
        12.3.2. MSCs
        12.3.3. Platelets
        12.3.4. Erythrocytes
        12.3.5. Natural Killer Cells
        12.3.6. Others
    12.4. Market Value Forecast By Application, 2017 - 2031
        12.4.1. Therapeutics
            12.4.1.1. Oncology
            12.4.1.2. Neurodegenerative Diseases
            12.4.1.3. Cardiovascular Diseases
            12.4.1.4. Infectious Diseases
            12.4.1.5. Cosmetics
        12.4.2. Diagnostics
    12.5. Market Value Forecast By End-user, 2017 - 2031
        12.5.1. Health Care Providers
        12.5.2. Pharmaceutical & Biotechnology Companies
        12.5.3. Others
    12.6. Market Value Forecast By Country, 2017 - 2031
        12.6.1. Germany
        12.6.2. U.K.
        12.6.3. France
        12.6.4. Spain
        12.6.5. Italy
        12.6.6. Rest of Europe
    12.7. Market Attractiveness Analysis
        12.7.1. By Exosome Type
        12.7.2. By Cell Source
        12.7.3. By Application
        12.7.4. By End-user
        12.7.5. By Country
13. Asia Pacific Exosome Technologies Market Analysis and Forecast
    13.1. Introduction
        13.1.1. Key Findings
    13.2. Market Value Forecast By Exosome Type, 2017 - 2031
        13.2.1. Loaded Cargos
            13.2.1.1. Peptide
            13.2.1.2. siRNA
            13.2.1.3. mRNA
            13.2.1.4. miRNA
            13.2.1.5. Protein
            13.2.1.6. Chemical
            13.2.1.7. Others
        13.2.2. Non-cargo
    13.3. Market Value Forecast By Cell Source, 2017 - 2031
        13.3.1. HEK293 Cells
        13.3.2. MSCs
        13.3.3. Platelets
        13.3.4. Erythrocytes
        13.3.5. Natural Killer Cells
        13.3.6. Others
    13.4. Market Value Forecast By Application, 2017 - 2031
        13.4.1. Therapeutics
            13.4.1.1. Oncology
            13.4.1.2. Neurodegenerative Diseases
            13.4.1.3. Cardiovascular Diseases
            13.4.1.4. Infectious Diseases
            13.4.1.5. Cosmetics
        13.4.2. Diagnostics
    13.5. Market Value Forecast By End-user, 2017 - 2031
        13.5.1. Health Care Providers
        13.5.2. Pharmaceutical & Biotechnology Companies
        13.5.3. Others
    13.6. Market Value Forecast By Country, 2017 - 2031
        13.6.1. China
        13.6.2. Japan
        13.6.3. India
        13.6.4. Australia & New Zealand
        13.6.5. Rest of Asia Pacific
    13.7. Market Attractiveness Analysis
        13.7.1. By Exosome Type
        13.7.2. By Cell Source
        13.7.3. By Application
        13.7.4. By End-user
        13.7.5. By Country
14. Latin America Exosome Technologies Market Analysis and Forecast
    14.1. Introduction
        14.1.1. Key Findings
    14.2. Market Value Forecast By Exosome Type, 2017 - 2031
        14.2.1. Loaded Cargos
            14.2.1.1. Peptide
            14.2.1.2. siRNA
            14.2.1.3. mRNA
            14.2.1.4. miRNA
            14.2.1.5. Protein
            14.2.1.6. Chemical
            14.2.1.7. Others
        14.2.2. Non-cargo
    14.3. Market Value Forecast By Cell Source, 2017 - 2031
        14.3.1. HEK293 Cells
        14.3.2. MSCs
        14.3.3. Platelets
        14.3.4. Erythrocytes
        14.3.5. Natural Killer Cells
        14.3.6. Others
    14.4. Market Value Forecast By Application, 2017 - 2031
        14.4.1. Therapeutics
            14.4.1.1. Oncology
            14.4.1.2. Neurodegenerative Diseases
            14.4.1.3. Cardiovascular Diseases
            14.4.1.4. Infectious Diseases
            14.4.1.5. Cosmetics
        14.4.2. Diagnostics
    14.5. Market Value Forecast By End-user, 2017 - 2031
        14.5.1. Health Care Providers
        14.5.2. Pharmaceutical & Biotechnology Companies
        14.5.3. Others
    14.6. Market Value Forecast By Country, 2017 - 2031
        14.6.1. Brazil
        14.6.2. Mexico
        14.6.3. Rest of Latin America
    14.7. Market Attractiveness Analysis
        14.7.1. By Exosome Type
        14.7.2. By Cell Source
        14.7.3. By Application
        14.7.4. By End-user
        14.7.5. By Country

15. Middle East & Africa Exosome Technologies Market Analysis and Forecast
    15.1. Introduction
        15.1.1. Key Findings
    15.2. Market Value Forecast By Exosome Type, 2017 - 2031
        15.2.1. Loaded Cargos
            15.2.1.1. Peptide
            15.2.1.2. siRNA
            15.2.1.3. mRNA
            15.2.1.4. miRNA
            15.2.1.5. Protein
            15.2.1.6. Chemical
            15.2.1.7. Others
        15.2.2. Non-cargo
    15.3. Market Value Forecast By Cell Source, 2017 - 2031
        15.3.1. HEK293 Cells
        15.3.2. MSCs
        15.3.3. Platelets
        15.3.4. Erythrocytes
        15.3.5. Natural Killer Cells
        15.3.6. Others
    15.4. Market Value Forecast By Application, 2017 - 2031
        15.4.1. Therapeutics
            15.4.1.1. Oncology
            15.4.1.2. Neurodegenerative Diseases
            15.4.1.3. Cardiovascular Diseases
            15.4.1.4. Infectious Diseases
            15.4.1.5. Cosmetics
        15.4.2. Diagnostics
    15.5. Market Value Forecast By End-user, 2017 - 2031
        15.5.1. Health Care Providers
        15.5.2. Pharmaceutical & Biotechnology Companies
        15.5.3. Others
    15.6. Market Value Forecast By Country, 2017 - 2031
        15.6.1. GCC Countries
        15.6.2. South Africa
        15.6.3. Rest of Middle East & Africa
    15.7. Market Attractiveness Analysis
        15.7.1. By Exosome Type
        15.7.2. By Cell Source
        15.7.3. By Application
        15.7.4. By End-user
        15.7.5. By Country

16. Competition Landscape
    16.1. Market Player – Competition Matrix (By Tier and Size of companies)
    16.2. Market Share Analysis By Company (2021)
    16.3. Company Profiles
        16.3.1. AEGLE Therapeutics
            16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.1.2. Test Type Portfolio
            16.3.1.3. Financial Overview
            16.3.1.4. SWOT Analysis
            16.3.1.5. Strategic Overview
        16.3.2. Aruna Bio, Inc.
            16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.2.2. Test Type Portfolio
            16.3.2.3. Financial Overview
            16.3.2.4. SWOT Analysis
            16.3.2.5. Strategic Overview
        16.3.3. Bio-Techne Corporation (Exosome Diagnostics, Inc.)
            16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.3.2. Test Type Portfolio
            16.3.3.3. Financial Overview
            16.3.3.4. SWOT Analysis
            16.3.3.5. Strategic Overview
        16.3.4. Carmine Therapeutics, Inc.
            16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.4.2. Test Type Portfolio
            16.3.4.3. Financial Overview
            16.3.4.4. SWOT Analysis
            16.3.4.5. Strategic Overview
        16.3.5. Codiak BioSciences, Inc.
            16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.5.2. Test Type Portfolio
            16.3.5.3. Financial Overview
            16.3.5.4. SWOT Analysis
            16.3.5.5. Strategic Overview
        16.3.6. Creative Biolabs
            16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.6.2. Test Type Portfolio
            16.3.6.3. Financial Overview
            16.3.6.4. SWOT Analysis
            16.3.6.5. Strategic Overview
        16.3.7. Danaher Corporation (Beckman Coulter, Inc.)
            16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.7.2. Test Type Portfolio
            16.3.7.3. Financial Overview
            16.3.7.4. SWOT Analysis
            16.3.7.5. Strategic Overview
        16.3.8. Fujifilm Holdings Corporation
            16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.8.2. Test Type Portfolio
            16.3.8.3. Financial Overview
            16.3.8.4. SWOT Analysis
            16.3.8.5. Strategic Overview
        16.3.9. NOVADIP Biosciences S.A.
            16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.9.2. Test Type Portfolio
            16.3.9.3. Financial Overview
            16.3.9.4. SWOT Analysis
            16.3.9.5. Strategic Overview
        16.3.10. OmniSpirant Limited
            16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.10.2. Test Type Portfolio
            16.3.10.3. Financial Overview
            16.3.10.4. SWOT Analysis
            16.3.10.5. Strategic Overview
        16.3.11. Thermo Fisher Scientific, Inc.
            16.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.11.2. Test Type Portfolio
            16.3.11.3. Financial Overview
            16.3.11.4. SWOT Analysis
            16.3.11.5. Strategic Overview



List of Figures

List of Figures

Figure 01: Global Exosome Technologies Market Value (US$ Mn) Forecast, 2017-2031

Figure 02: Global Exosome Technologies Market Value Share Analysis, by Exosome Type, 2022 and 2031

Figure 03: Global Exosome Technologies Market Attractiveness Analysis, by Exosome Type, 2023-2031

Figure 04: Global Exosome Technologies Market (US$ Mn), by Loaded Cargos, 2017-2031

Figure 05: Global Exosome Technologies Market (US$ Mn), by Non-cargo, 2017-2031

Figure 06: Global Exosome Technologies Market Value Share Analysis, by Cell Source, 2022 and 2031

Figure 07: Global Exosome Technologies Market Attractiveness Analysis, by Cell Source, 2023-2031

Figure 08: Global Exosome Technologies Market (US$ Mn), by HEK293 Cells, 2017-2031

Figure 09 Global Exosome Technologies Market (US$ Mn), by MSCs, 2017-2031

Figure 10: Global Exosome Technologies Market (US$ Mn), by Platelets, 2017-2031

Figure 11: Global Exosome Technologies Market (US$ Mn), by Erythrocytes, 2017-2031

Figure 12: Global Exosome Technologies Market (US$ Mn), by Natural Killer Cells, 2017-2031

Figure 13: Global Exosome Technologies Market (US$ Mn), by Others, 2017-2031

Figure 14: Global Exosome Technologies Market Value Share Analysis, by Application, 2022 and 2031

Figure 15: Global Exosome Technologies Market Attractiveness Analysis, by Application, 2023-2031

Figure 16: Global Exosome Technologies Market (US$ Mn), by Therapeutics, 2017-2031

Figure 17: Global Exosome Technologies Market (US$ Mn), by Diagnostics, 2017-2031

Figure 18: Global Exosome Technologies Market Value Share Analysis, by End-user, 2022 and 2031

Figure 19: Global Exosome Technologies Market Attractiveness Analysis, by End-user, 2023-2031

Figure 20: Global Exosome Technologies Market (US$ Mn), by Health Care Providers, 2017-2031

Figure 21: Global Exosome Technologies Market (US$ Mn), by Pharmaceutical & Biotechnology Companies, 2017-2031

Figure 22: Global Exosome Technologies Market (US$ Mn), by Others, 2017-2031

Figure 23: Global Exosome Technologies Market Value Share Analysis, by Region, 2022 and 2031

Figure 24: Global Exosome Technologies Market Attractiveness Analysis, by Region, 2023-2031

Figure 25: North America Exosome Technologies Market Value (US$ Mn) Forecast, 2017-2031

Figure 26: North America Exosome Technologies Market Value Share Analysis, by Country, 2022 and 2031

Figure 27: North America Exosome Technologies Market Attractiveness Analysis, by Country, 2023-2031

Figure 28: North America Exosome Technologies Market Value Share Analysis, by Exosome Type, 2022 and 2031

Figure 29: North America Exosome Technologies Market Attractiveness Analysis, by Exosome Type, 2023-2031

Figure 30: North America Exosome Technologies Market Value Share Analysis, by Cell Source, 2022 and 2031

Figure 31: North America Exosome Technologies Market Attractiveness Analysis, by Cell Source, 2023-2031

Figure 32: North America Exosome Technologies Market Value Share Analysis, by Application, 2022 and 2031

Figure 33: North America Exosome Technologies Market Attractiveness Analysis, by Application, 2023-2031

Figure 34: North America Exosome Technologies Market Value Share Analysis, by End-user, 2022 and 2031

Figure 35: North America Exosome Technologies Market Attractiveness Analysis, by End-user, 2023-2031

Figure 36: Europe Exosome Technologies Market Value (US$ Mn) Forecast, 2017-2031

Figure 37: Europe Exosome Technologies Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

Figure 38: Europe Exosome Technologies Market Attractiveness Analysis, by Country/Sub-region, 2023-2031

Figure 39: Europe Exosome Technologies Market Value Share Analysis, by Exosome Type, 2022 and 2031

Figure 40: Europe Exosome Technologies Market Attractiveness Analysis, by Exosome Type, 2023-2031

Figure 41: Europe Exosome Technologies Market Value Share Analysis, by Cell Source, 2022 and 2031

Figure 42: Europe Exosome Technologies Market Attractiveness Analysis, by Cell Source, 2023-2031

Figure 43: Europe Exosome Technologies Market Value Share Analysis, by Application, 2022 and 2031

Figure 44: Europe Exosome Technologies Market Attractiveness Analysis, by Application, 2023-2031

Figure 45: Europe Exosome Technologies Market Value Share Analysis, by End-user, 2022 and 2031

Figure 46: Europe Exosome Technologies Market Attractiveness Analysis, by End-user, 2023-2031

Figure 47: Asia Pacific Exosome Technologies Market Value (US$ Mn) Forecast, 2017-2031

Figure 48: Asia Pacific Exosome Technologies Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

Figure 49: Asia Pacific Exosome Technologies Market Attractiveness Analysis, by Country/Sub-region, 2023-2031

Figure 50: Asia Pacific Exosome Technologies Market Value Share Analysis, by Exosome Type, 2022 and 2031

Figure 51: Asia Pacific Exosome Technologies Market Attractiveness Analysis, by Exosome Type, 2023-2031

Figure 52: Asia Pacific Exosome Technologies Market Value Share Analysis, by Cell Source, 2022 and 2031

Figure 53: Asia Pacific Exosome Technologies Market Attractiveness Analysis, by Cell Source, 2023-2031

Figure 54: Asia Pacific Exosome Technologies Market Value Share Analysis, by Application, 2022 and 2031

Figure 55: Asia Pacific Exosome Technologies Market Attractiveness Analysis, by Application, 2023-2031

Figure 56: Asia Pacific Exosome Technologies Market Value Share Analysis, by End-user, 2022 and 2031

Figure 57: Asia Pacific Exosome Technologies Market Attractiveness Analysis, by End-user, 2023-2031

Figure 58: Latin America Exosome Technologies Market Value (US$ Mn) Forecast, 2017-2031

Figure 59: Latin America Exosome Technologies Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

Figure 60: Latin America Exosome Technologies Market Attractiveness Analysis, by Country/Sub-region, 2023-2031

Figure 61: Latin America Exosome Technologies Market Value Share Analysis, by Exosome Type, 2022 and 2031

Figure 62: Latin America Exosome Technologies Market Attractiveness Analysis, by Exosome Type, 2023-2031

Figure 63: Latin America Exosome Technologies Market Value Share Analysis, by Cell Source, 2022 and 2031

Figure 64: Latin America Exosome Technologies Market Attractiveness Analysis, by Cell Source, 2023-2031

Figure 65: Latin America Exosome Technologies Market Value Share Analysis, by Application, 2022 and 2031

Figure 66: Latin America Exosome Technologies Market Attractiveness Analysis, by Application, 2023-2031

Figure 67: Latin America Exosome Technologies Market Value Share Analysis, by End-user, 2022 and 2031

Figure 68: Latin America Exosome Technologies Market Attractiveness Analysis, by End-user, 2023-2031

Figure 69: Middle East & Africa Exosome Technologies Market Value (US$ Mn) Forecast, 2017-2031

Figure 70: Middle East & Africa Exosome Technologies Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

Figure 71: Middle East & Africa Exosome Technologies Market Attractiveness Analysis, by Country/Sub-region, 2023-2031

Figure 72: Middle East & Africa Exosome Technologies Market Value Share Analysis, by Exosome Type, 2022 and 2031

Figure 73: Middle East & Africa Exosome Technologies Market Attractiveness Analysis, by Exosome Type, 2023-2031

Figure 74: Middle East & Africa Exosome Technologies Market Value Share Analysis, by Cell Source, 2022 and 2031

Figure 75: Middle East & Africa Exosome Technologies Market Attractiveness Analysis, by Cell Source, 2023-2031

Figure 76: Middle East & Africa Exosome Technologies Market Value Share Analysis, by Application, 2022 and 2031

Figure 77: Middle East & Africa Exosome Technologies Market Attractiveness Analysis, by Application, 2023-2031

Figure 78: Middle East & Africa Exosome Technologies Market Value Share Analysis, by End-user, 2022 and 2031

Figure 79: Middle East & Africa Exosome Technologies Market Attractiveness Analysis, by End-user, 2023-2031

Figure 80: Global Exosome Technologies Market Share Analysis, by Company, 2022

List of Tables

List of Tables

Table 01: Global Exosome Technologies Market Value (US$ Mn) Forecast, by Exosome Type, 2017-2031

Table 02: Global Exosome Technologies Market Value (US$ Mn) Forecast, by Loaded Cargos, 2017-2031

Table 03: Global Exosome Technologies Market Value (US$ Mn) Forecast, by Cell Source, 2017-2031

Table 04: Global Exosome Technologies Market Value (US$ Mn) Forecast, by Application, 2017-2031

Table 05: Global Exosome Technologies Market Value (US$ Mn) Forecast, by Therapeutics, 2017-2031

Table 06: Global Exosome Technologies Market Value (US$ Mn) Forecast, by End-user, 2017-2031

Table 07: Global Exosome Technologies Market Value (US$ Mn) Forecast, by Region, 2017-2031

Table 08: North America Exosome Technologies Market Value (US$ Mn) Forecast, by Country, 2017-2031

Table 09: North America Exosome Technologies Market Value (US$ Mn) Forecast, by Exosome Type, 2017-2031

Table 10: North America Exosome Technologies Market Value (US$ Mn) Forecast, by Loaded Cargos, 2017-2031

Table 11: North America Exosome Technologies Market Value (US$ Mn) Forecast, by Cell Source, 2017-2031

Table 12: North America Exosome Technologies Market Value (US$ Mn) Forecast, by Application, 2017-2031

Table 13: North America Exosome Technologies Market Value (US$ Mn) Forecast, by Therapeutics, 2017-2031

Table 14: North America Exosome Technologies Market Value (US$ Mn) Forecast, by End-user, 2017-2031

Table 15: Europe Exosome Technologies Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031

Table 16: Europe Exosome Technologies Market Value (US$ Mn) Forecast, by Exosome Type, 2017-2031

Table 17: Europe Exosome Technologies Market Value (US$ Mn) Forecast, by Loaded Cargos, 2017-2031

Table 18: Europe Exosome Technologies Market Value (US$ Mn) Forecast, by Cell Source, 2017-2031

Table 19: Europe Exosome Technologies Market Value (US$ Mn) Forecast, by Application, 2017-2031

Table 20: Europe Exosome Technologies Market Value (US$ Mn) Forecast, by Therapeutics, 2017-2031

Table 21: Europe Exosome Technologies Market Value (US$ Mn) Forecast, by End-user, 2017-2031

Table 22: Asia Pacific Exosome Technologies Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031

Table 23: Asia Pacific Exosome Technologies Market Value (US$ Mn) Forecast, by Exosome Type, 2017-2031

Table 24: Asia Pacific Exosome Technologies Market Value (US$ Mn) Forecast, by Loaded Cargos, 2017-2031

Table 25: Asia Pacific Exosome Technologies Market Value (US$ Mn) Forecast, by Cell Source, 2017-2031

Table 26: Asia Pacific Exosome Technologies Market Value (US$ Mn) Forecast, by Application, 2017-2031

Table 27: Asia Pacific Exosome Technologies Market Value (US$ Mn) Forecast, by Therapeutics, 2017-2031

Table 28: Asia Pacific Exosome Technologies Market Value (US$ Mn) Forecast, by End-user, 2017-2031

Table 29: Latin America Exosome Technologies Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031

Table 30: Latin America Exosome Technologies Market Value (US$ Mn) Forecast, by Exosome Type, 2017-2031

Table 31: Latin America Exosome Technologies Market Value (US$ Mn) Forecast, by Loaded Cargos, 2017-2031

Table 32: Latin America Exosome Technologies Market Value (US$ Mn) Forecast, by Cell Source, 2017-2031

Table 33: Latin America Exosome Technologies Market Value (US$ Mn) Forecast, by Application, 2017-2031

Table 34: Latin America Exosome Technologies Market Value (US$ Mn) Forecast, by Therapeutics, 2017-2031

Table 35: Latin America Exosome Technologies Market Value (US$ Mn) Forecast, by End-user, 2017-2031

Table 36: Middle East & Africa Exosome Technologies Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031

Table 37: Middle East & Africa Exosome Technologies Market Value (US$ Mn) Forecast, by Exosome Type, 2017-2031

Table 38: Middle East & Africa Exosome Technologies Market Value (US$ Mn) Forecast, by Loaded Cargos, 2017-2031

Table 39: Middle East & Africa Exosome Technologies Market Value (US$ Mn) Forecast, by Cell Source, 2017-2031

Table 40: Middle East & Africa Exosome Technologies Market Value (US$ Mn) Forecast, by Application, 2017-2031

Table 41: Middle East & Africa Exosome Technologies Market Value (US$ Mn) Forecast, by Therapeutics, 2017-2031

Table 42: Middle East & Africa Exosome Technologies Market Value (US$ Mn) Forecast, by End-user, 2017-2031